Evidence map›Paper›PMID 40631944›Full record

ReviewAngewandte Chemie (International ed. in English)2025

Collision-Induced Fragmentation of Oligosaccharides: Mechanistic Insights for Mass Spectrometry-Based Glycomics.

Niklas Geue, Marc Safferthal, Kevin Pagel

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Stereoselectivity of Galactosylation Reactions In Vacuo.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Mass Spectrometric Determination of Site-SpecificJournal of the American Society for Mass Spectrometry · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Niklas GeueInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID 0000-0002-5216-8353
Marc SafferthalInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID 0009-0006-9267-3940
Kevin PagelInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Altensteinstraße 23a, 14195, Berlin, Germany.ORCID 0000-0001-8054-4718

Funding

Deutsche Forschungsgemeinschaft 431232613Deutsche Forschungsgemeinschaft SFB1449Deutsche Forschungsgemeinschaft: Walter Benjamin Fellowship 559720072ERC Consolidator Grant "Glycospec" ERC-2019-CoG-863934-GlycoSpec
6 · The paper itself

Abstract

Structural alterations in oligosaccharides are often associated with disease, positioning clinical glycomics as an emerging tool for diagnostics. This is most commonly achieved using a controlled collision-induced dissociation (CID) of larger oligosaccharides into fragments and measuring their mass in a mass spectrometer. Due to the complexity of oligosaccharides, and particularly their unusual fragmentation mechanisms, the underlying processes are poorly understood. Deciphering glycan fragmentation and making it understandable is highly desirable and would transform the field of glycomics from an expert technique into a widely applicable tool available to non-specialists. Here, we review the current knowledge of glycan fragmentation mechanisms in CID, with particular emphasis on hexose migrations and the anomeric memory. We discuss challenges and perspectives for future investigations, opening the window to widespread use of glycomics in clinical applications based on a fundamental understanding of glycan fragmentation.

Indexed as

GlycomicsMass SpectrometryOligosaccharidesHumansOligosaccharidesCollision‐induced dissociationGas‐phase mechanismsGas‐phase spectroscopyGlycan fragmentationIon mobility mass spectrometry (IM‐MS)

Identifiers

PMID40631944
PMCPMC12338385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.